Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma, Ewing 4Rhabdomyosarcoma 4Osteosarcoma 4Recurrence 2Neuroblastoma 2Wilms Tumor 1Sarcoma 1Rhabdoid Tumor 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Hepatoblastoma 1Gliosarcoma 1Glioblastoma 1Astrocytoma 1

Interventions

tazemetostat 6X-Rays 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Cyclophosphamide 6Specimen Handling 5Etoposide 5Carboplatin 5etoposide phosphate 4Temozolomide 4Nuclear Medicine Department, Hospital 4Granulocyte Colony-Stimulating Factor 4palbociclib 3Topotecan 3Thiotepa 3Sirolimus 3Mesna 3Melphalan 3Ifosfamide 3Filgrastim 3Busulfan 3Biopsy 3ulixertinib 2tipifarnib 2selpercatinib 2omburtamab I-131 2olaparib 2larotrectinib 2ivosidenib 2fludarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × irinotecan sucrosofate × Sarcoma × Clear all
NCT04901702 2026-05-19

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
90 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡